276 related articles for article (PubMed ID: 4130697)
1. The IgM and IgA immune response to the TNP determinant group in BALB-c mice.
Mauch P; Bridges SH; Little KD; Little JR
J Immunol; 1974 Feb; 112(2):812-21. PubMed ID: 4130697
[No Abstract] [Full Text] [Related]
2. Regulation of the immune response. IV. Antibody-mediated suppression of the immune response to haptens and heterologous erythrocyte antigens in vitro.
Kappler JW; van der Hoven A; Dharmarajan U; Hoffmann M
J Immunol; 1973 Oct; 111(4):1228-35. PubMed ID: 4580667
[No Abstract] [Full Text] [Related]
3. Development of primary M, G, and A anti-TNP plaque-forming cell responses in vitro.
Bluestein HG; Pierce CW
J Immunol; 1973 Jul; 111(1):130-6. PubMed ID: 4576584
[No Abstract] [Full Text] [Related]
4. Carrier-determined tolerance in vitro.
Galanaud P; Aldo-Benson M; Borel Y
J Immunol; 1975 Jan; 114(1 Pt 1):141-4. PubMed ID: 46237
[TBL] [Abstract][Full Text] [Related]
5. Use of 2-mercaptoethanol for distinguishing between IgM and IgG antibody-producing cells of mice immunized with bovine globulin.
Hosono M; Muramatsu S
J Immunol; 1972 Oct; 109(4):857-63. PubMed ID: 4116361
[No Abstract] [Full Text] [Related]
6. The immune response in mice to the haptenic determinant DNP coupled to a thymus-independent carrier (levan).
Del Guercio P; Leuchars E
J Immunol; 1972 Nov; 109(5):951-6. PubMed ID: 4116765
[No Abstract] [Full Text] [Related]
7. Cellular events in tolerance. II. Similar specificity of carrier cross-tolerance in vivo and cross-stimulation in vitro.
Scott DW
J Immunol; 1974 Apr; 112(4):1354-9. PubMed ID: 4131164
[No Abstract] [Full Text] [Related]
8. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
Fenton MR; Havas HF
J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
[TBL] [Abstract][Full Text] [Related]
9. The effect of the immunogenicity of the heterologous carrier on the early secondary anti-2,4-dinitrophenyl (DNP) response of BALB-c mice.
Havas HF; Pickard AR
J Immunol; 1972 Oct; 109(4):791-800. PubMed ID: 4116359
[No Abstract] [Full Text] [Related]
10. Clonal nature of the immune response to phosphorylcholine. II. Idiotypic specificity and binding characteristics of anti-phosphorylcholine antibodies.
Claflin JL; Lieberman R; Davie JM
J Immunol; 1974 May; 112(5):1747-56. PubMed ID: 4150447
[No Abstract] [Full Text] [Related]
11. Original antigenic sin at the cellular level. I. Antibodies produced by individual cells against cross-reacting haptens.
Deutsch S; Bussard AE
Eur J Immunol; 1972 Aug; 2(4):374-8. PubMed ID: 4117284
[No Abstract] [Full Text] [Related]
12. Surface immunoglobulins on circulating lymphocytes in mouse and human plasmacytoma.
Heller P; Yakulis V; Bhoopalam N; Costea N; Cabana V; Nathan RD
Trans Assoc Am Physicians; 1972; 85():192-202. PubMed ID: 4633774
[No Abstract] [Full Text] [Related]
13. Preparation of dinitrofluorobenzene-treated sheep erythrocytes for detection of anti-DNP plaque-forming cells.
Trump GN
J Immunol; 1972 Oct; 109(4):754-60. PubMed ID: 4116358
[No Abstract] [Full Text] [Related]
14. A rapid method for the isolation of functional thymus-derived murine lymphocytes.
Julius MH; Simpson E; Herzenberg LA
Eur J Immunol; 1973 Oct; 3(10):645-9. PubMed ID: 4587740
[No Abstract] [Full Text] [Related]
15. Effect of chronic viral infection on the immune system. I. Comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice.
Oldstone MB; Tishon A; Chiller JM; Weigle WO; Dixon FJ
J Immunol; 1973 May; 110(5):1268-78. PubMed ID: 4121421
[No Abstract] [Full Text] [Related]
16. The enhancement of a primary in vitro anti-hapten response by carrier priming.
Trowbridge IS
Eur J Immunol; 1972 Dec; 2(6):558-65. PubMed ID: 4569998
[No Abstract] [Full Text] [Related]
17. Measurement of antibody release from single cells. 3. Rate of release of IgM from MOPC 104E plasmacytoma.
Ghanta VK; McGhee JR; Hamlin NM; Hiramoto RN
J Immunol; 1974 Jan; 112(1):266-70. PubMed ID: 4590822
[No Abstract] [Full Text] [Related]
18. Antibody-dependent cell-mediated cytotoxicity. I. Differentiation from antibody-independent cytotoxicity by "normal" IgG.
Scornik JC; Cosenza H; Lee W; Köhler H; Rowley DA
J Immunol; 1974 Nov; 113(5):1510-8. PubMed ID: 4153633
[No Abstract] [Full Text] [Related]
19. The mechanism of bone marrow-derived (B) lymphocyte activation. I. Early events in antigen-induced triggering in the presence of polymerized flagellin.
Schrader JW
Eur J Immunol; 1974 Jan; 4(1):14-20. PubMed ID: 4605291
[No Abstract] [Full Text] [Related]
20. The immune capacity of lymphocytes after cross-linking of surface immunoglobulin receptors by antibody.
Katz DH; Unanue ER
J Immunol; 1972 Nov; 109(5):1022-30. PubMed ID: 5079090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
